Circulating tumor cells in sarcomas: a brief review

Area of Science:

• Oncology
• Molecular Diagnostics

Background:

• Sarcomas are rare but aggressive cancers with high mortality.
• Circulating tumor cells (CTCs) have proven utility in epithelial cancers.

Purpose of the Study:

• To review the current knowledge on CTC detection in sarcomas.
• To explore the potential clinical utility of CTCs in sarcoma diagnosis and management.

Main Methods:

• Review of existing studies on CTC detection in sarcoma.
• Methods include reverse transcriptase polymerase chain reaction (RT-PCR) and antibody-based detection (e.g., flow cytometry).
• Detection targets include gene fusion products in translocation sarcomas, universal markers like Vimentin, and specific markers like Type I Collagen in osteosarcoma.

Main Results:

• CTC detection in sarcoma is feasible, particularly in translocation sarcomas using gene fusion products.
• Studies confirm the feasibility in Ewing's sarcoma, synovial sarcoma, and alveolar soft part sarcoma.
• Exploration of universal and specific sarcoma markers is ongoing.

Conclusions:

• CTC detection in sarcoma is an emerging field with potential for improved diagnosis, recurrence prediction, and patient management.
• Further research is needed to fully establish CTCs as a clinical tool for sarcomas.